Chaitanya K Valiveti
Overview
Explore the profile of Chaitanya K Valiveti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valiveti C, Rajput M, Thakur N, Momin T, Bhowmik M, Tummala H
Vaccines (Basel)
. 2024 Oct;
12(10).
PMID: 39460287
Influenza virus enters the host body through the mucosal surface of the respiratory tract. An efficient immune response at the mucosal site can interfere with virus entry and prevent infection....
2.
Valiveti C, Kumar B, Singh A, Biradar S, Ahmad R, Singh A, et al.
Cells
. 2024 Jun;
13(11.
PMID: 38891089
Inflammatory bowel disease (IBD) is a chronic gut disorder that also elevates the risk of colorectal cancer (CRC). The global incidence and severity of IBD are rising, yet existing therapies...
3.
Bakkari M, Valiveti C, Kaushik R, Tummala H
Mol Pharm
. 2021 May;
18(6):2233-2241.
PMID: 34010002
Eliciting a robust immune response at mucosal sites is critical in preventing the entry of mucosal pathogens such as influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This task...
4.
Sankaranarayanan R, Valiveti C, Dachineni R, Kumar D, Lick T, Bhat G
Mol Med Rep
. 2019 Nov;
21(1):20-34.
PMID: 31746356
Although compelling evidence exists on the ability of aspirin to treat colorectal cancer (CRC), and numerous theories and targets have been proposed, a consensus has not been reached regarding its...
5.
Sankaranarayanan R, Valiveti C, Kumar D, Van Slambrouck S, Kesharwani S, Seefeldt T, et al.
Cancers (Basel)
. 2019 Mar;
11(3).
PMID: 30917530
Flavonoids have emerged as promising compounds capable of preventing colorectal cancer (CRC) due to their anti-oxidant and anti-inflammatory properties. It is hypothesized that the metabolites of flavonoids are primarily responsible...
6.
Kesharwani S, Ahmad R, Bakkari M, Rajput M, Dachineni R, Valiveti C, et al.
J Control Release
. 2018 Aug;
290:165-179.
PMID: 30142410
Inflammatory Bowel Diseases (IBD) is a debilitating condition that affects ~70,000 new people every year and has been described as "an expensive disease with no known cure". In addition, IBD...